Relmada Therapeutics Inc (RLMD)

21.70
NASDAQ
Prev Close 22.21
Day Low/High 21.26 / 22.68
52 Wk Low/High 16.23 / 39.66
Exchange NASDAQ
Shares Outstanding 29.99B
Market Cap 666.10M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

The Biggest Positive Now Is That Individual Stock Picking Is Improving

In This Market, Err on the Side of Caution

Overconfident Bears Have Missed Out on Great Opportunities

Overconfident Bears Have Missed Out on Great Opportunities

I am carrying a large cash balance -- but not because I'm bearish.

From Our Partners

Jefferies starts Relmada at Buy, sees 50-100% upside potential

The Fly

Relmada Therapeutics initiated with a Buy at Jefferies

The Fly

Relmada Therapeutics initiated with an Outperform at SVB Leerink

The Fly

Relmada Therapeutics initiated with an Outperform at SVB Leerink

The Fly

Relmada Therapeutics initiated with a Buy at Guggenheim

The Fly

Don't Be Fooled By Relmada's Clinical Data Readout

SeekingAlpha

Relmada prices $100M equity offering

SeekingAlpha

Relmada launches equity offering; shares down 5% after hours

SeekingAlpha

Daily Insider Ratings Round Up 10/21/19

SeekingAlpha

Relmada files for $200M mixed shelf

SeekingAlpha

Relmada up 84% premarket on positive REL-1017 data in treatment-resistant depression

SeekingAlpha

Relmada uplisted to Nasdaq

SeekingAlpha

Relmada Therapeutics announces 1-for-4 reverse stock split for proposed uplisting to NASDAQ

SeekingAlpha

Relmada to reverse split shares 1:4

SeekingAlpha

Relmada advancing depression candidate REL-1017, mid-stage data readout this quarter

SeekingAlpha

Columnist Conversation

COLUMNIST TWEETS

REAL MONEY POST INDUSTRIAL AVERAGE